View in EDS HTML Full Text PDF Full Text

A Bayesian adaptive randomized phase II multicenter trial of bevacizumab with or without vorinostat in adults with recurrent glioblastoma.

Saved in:
Bibliographic Details
Title: A Bayesian adaptive randomized phase II multicenter trial of bevacizumab with or without vorinostat in adults with recurrent glioblastoma.
Authors: Puduvalli VK; Division of Neuro-Oncoology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio., Wu J; Neuro-Oncology Branch, National Institute of Health, Bethesda, Maryland., Yuan Y; Department of Biostatistics, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas., Armstrong TS; Neuro-Oncology Branch, National Institute of Health, Bethesda, Maryland., Vera E; Neuro-Oncology Branch, National Institute of Health, Bethesda, Maryland., Wu J; Department of Biostatistics, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas., Xu J; Division of Neuro-Oncoology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio., Giglio P; Division of Neuro-Oncoology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio., Colman H; Department of Neurosurgery, Huntsman Cancer Center, University of Utah, Salt Lake City, Utah., Walbert T; Department of Neurology and Neurosurgery, Henry Ford Health System, Detroit, Michigan., Raizer J; Department of Neurology, Northwestern University, Chicago, Illinois., Groves MD; Texas Oncology Austin Brain Tumor Center, Austin, Texas., Tran D; Department of Medicine, Washington University, St Louis, Missouri., Iwamoto F; Division of Neurooncology, Columbia University, New York, New York., Avgeropoulos N; Orlando Health UF Health Cancer Center, Orlando, Florida., Paleologos N; Advocate Health Care, Downers Grove, Illinois., Fink K; Baylor University Medical Center, Dallas, Texas., Peereboom D; Department of Medicine, Cleveland Clinic, Cleveland, Ohio., Chamberlain M; Department of Neurology, University of Washington, Seattle, Washington., Merrell R; Department of Neurology, North Shore University Health System, Evanston, Illinois., Penas Prado M; Department of Neuro-Oncology, The University of  Texas MD Anderson Cancer Center, Houston, Texas., Yung WKA; Department of Neuro-Oncology, The University of  Texas MD Anderson Cancer Center, Houston, Texas., Gilbert MR; Neuro-Oncology Branch, National Institute of Health, Bethesda, Maryland.
Source: Neuro-oncology [Neuro Oncol] 2020 Oct 14; Vol. 22 (10), pp. 1505-1515.
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't; Adaptive Clinical Trial
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 32166308
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A Bayesian adaptive randomized phase II multicenter trial of bevacizumab with or without vorinostat in adults with recurrent glioblastoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Puduvalli+VK%22">Puduvalli VK</searchLink>; Division of Neuro-Oncoology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.<br /><searchLink fieldCode="AU" term="%22Wu+J%22">Wu J</searchLink>; Neuro-Oncology Branch, National Institute of Health, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Yuan+Y%22">Yuan Y</searchLink>; Department of Biostatistics, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Armstrong+TS%22">Armstrong TS</searchLink>; Neuro-Oncology Branch, National Institute of Health, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Vera+E%22">Vera E</searchLink>; Neuro-Oncology Branch, National Institute of Health, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Wu+J%22">Wu J</searchLink>; Department of Biostatistics, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Xu+J%22">Xu J</searchLink>; Division of Neuro-Oncoology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.<br /><searchLink fieldCode="AU" term="%22Giglio+P%22">Giglio P</searchLink>; Division of Neuro-Oncoology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.<br /><searchLink fieldCode="AU" term="%22Colman+H%22">Colman H</searchLink>; Department of Neurosurgery, Huntsman Cancer Center, University of Utah, Salt Lake City, Utah.<br /><searchLink fieldCode="AU" term="%22Walbert+T%22">Walbert T</searchLink>; Department of Neurology and Neurosurgery, Henry Ford Health System, Detroit, Michigan.<br /><searchLink fieldCode="AU" term="%22Raizer+J%22">Raizer J</searchLink>; Department of Neurology, Northwestern University, Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22Groves+MD%22">Groves MD</searchLink>; Texas Oncology Austin Brain Tumor Center, Austin, Texas.<br /><searchLink fieldCode="AU" term="%22Tran+D%22">Tran D</searchLink>; Department of Medicine, Washington University, St Louis, Missouri.<br /><searchLink fieldCode="AU" term="%22Iwamoto+F%22">Iwamoto F</searchLink>; Division of Neurooncology, Columbia University, New York, New York.<br /><searchLink fieldCode="AU" term="%22Avgeropoulos+N%22">Avgeropoulos N</searchLink>; Orlando Health UF Health Cancer Center, Orlando, Florida.<br /><searchLink fieldCode="AU" term="%22Paleologos+N%22">Paleologos N</searchLink>; Advocate Health Care, Downers Grove, Illinois.<br /><searchLink fieldCode="AU" term="%22Fink+K%22">Fink K</searchLink>; Baylor University Medical Center, Dallas, Texas.<br /><searchLink fieldCode="AU" term="%22Peereboom+D%22">Peereboom D</searchLink>; Department of Medicine, Cleveland Clinic, Cleveland, Ohio.<br /><searchLink fieldCode="AU" term="%22Chamberlain+M%22">Chamberlain M</searchLink>; Department of Neurology, University of Washington, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Merrell+R%22">Merrell R</searchLink>; Department of Neurology, North Shore University Health System, Evanston, Illinois.<br /><searchLink fieldCode="AU" term="%22Penas+Prado+M%22">Penas Prado M</searchLink>; Department of Neuro-Oncology, The University of  Texas MD Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Yung+WKA%22">Yung WKA</searchLink>; Department of Neuro-Oncology, The University of  Texas MD Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Gilbert+MR%22">Gilbert MR</searchLink>; Neuro-Oncology Branch, National Institute of Health, Bethesda, Maryland.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100887420%22">Neuro-oncology</searchLink> [Neuro Oncol] 2020 Oct 14; Vol. 22 (10), pp. 1505-1515.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't; Adaptive Clinical Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100887420 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1523-5866 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215228517%22">15228517 </searchLink><i>NLM ISO Abbreviation: </i>Neuro Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32166308
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/neuonc/noaa062
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1505
    Titles:
      – TitleFull: A Bayesian adaptive randomized phase II multicenter trial of bevacizumab with or without vorinostat in adults with recurrent glioblastoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Puduvalli VK
      – PersonEntity:
          Name:
            NameFull: Wu J
      – PersonEntity:
          Name:
            NameFull: Yuan Y
      – PersonEntity:
          Name:
            NameFull: Armstrong TS
      – PersonEntity:
          Name:
            NameFull: Vera E
      – PersonEntity:
          Name:
            NameFull: Wu J
      – PersonEntity:
          Name:
            NameFull: Xu J
      – PersonEntity:
          Name:
            NameFull: Giglio P
      – PersonEntity:
          Name:
            NameFull: Colman H
      – PersonEntity:
          Name:
            NameFull: Walbert T
      – PersonEntity:
          Name:
            NameFull: Raizer J
      – PersonEntity:
          Name:
            NameFull: Groves MD
      – PersonEntity:
          Name:
            NameFull: Tran D
      – PersonEntity:
          Name:
            NameFull: Iwamoto F
      – PersonEntity:
          Name:
            NameFull: Avgeropoulos N
      – PersonEntity:
          Name:
            NameFull: Paleologos N
      – PersonEntity:
          Name:
            NameFull: Fink K
      – PersonEntity:
          Name:
            NameFull: Peereboom D
      – PersonEntity:
          Name:
            NameFull: Chamberlain M
      – PersonEntity:
          Name:
            NameFull: Merrell R
      – PersonEntity:
          Name:
            NameFull: Penas Prado M
      – PersonEntity:
          Name:
            NameFull: Yung WKA
      – PersonEntity:
          Name:
            NameFull: Gilbert MR
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 14
              M: 10
              Text: 2020 Oct 14
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-electronic
              Value: 1523-5866
          Numbering:
            – Type: volume
              Value: 22
            – Type: issue
              Value: 10
          Titles:
            – TitleFull: Neuro-oncology
              Type: main
ResultId 1